Literature DB >> 12526021

Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation.

Tammy Kielian1, Paul D Drew.   

Abstract

Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) plays a critical role in glucose and lipid metabolism. More recently, PPAR-gamma ligands have been reported to inhibit the expression of proinflammatory molecules by monocytes/macrophages. Of relevance to CNS disease is that PPAR-gamma agonists have been demonstrated to have similar effects on microglia. PPAR-gamma agonists also ameliorate experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. This Mini-Review summarizes the effects of PPAR-gamma agonists in mediating immune responses and the potential of these agonists in the treatment of inflammatory disorders of the CNS. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12526021     DOI: 10.1002/jnr.10501

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  48 in total

1.  PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage.

Authors:  Maria Paola Simula; Renato Cannizzaro; Vincenzo Canzonieri; Alessandro Pavan; Stefania Maiero; Giuseppe Toffoli; Valli De Re
Journal:  Mol Med       Date:  2010-03-03       Impact factor: 6.354

Review 2.  Involvement of PPAR nuclear receptors in tissue injury and wound repair.

Authors:  Liliane Michalik; Walter Wahli
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

3.  PPARs: a new target for neuroprotection.

Authors:  R Bordet; P Gelé; P Duriez; J-C Fruchart
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

4.  Peroxisome proliferator-activated receptor-gamma activation suppresses HIV-1 replication in an animal model of encephalitis.

Authors:  Raghava Potula; Servio H Ramirez; Bryan Knipe; Jessica Leibhart; Kathy Schall; David Heilman; Brenda Morsey; Aaron Mercer; Anil Papugani; Huanyu Dou; Yuri Persidsky
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

5.  Gng12 is a novel negative regulator of LPS-induced inflammation in the microglial cell line BV-2.

Authors:  Kelley C Larson; Maciej Lipko; Michal Dabrowski; Michael P Draper
Journal:  Inflamm Res       Date:  2009-07-01       Impact factor: 4.575

6.  9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes.

Authors:  Jihong Xu; Paul D Drew
Journal:  J Neuroimmunol       Date:  2005-11-21       Impact factor: 3.478

7.  15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.

Authors:  Nirmal K Phulwani; Douglas L Feinstein; Vitaliy Gavrilyuk; Candan Akar; Tammy Kielian
Journal:  J Neurochem       Date:  2006-12       Impact factor: 5.372

8.  Effects of Wy14643 on hepatic ischemia reperfusion injury in rats.

Authors:  Si-Qi Xu; Yuan-Hai Li; Sheng-Hong Hu; Ke Chen; Liu-Yi Dong
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

9.  PPARG: Gene Expression Regulation and Next-Generation Sequencing for Unsolved Issues.

Authors:  Valerio Costa; Maria Assunta Gallo; Francesca Letizia; Marianna Aprile; Amelia Casamassimi; Alfredo Ciccodicola
Journal:  PPAR Res       Date:  2010-09-08       Impact factor: 4.964

10.  Regulation of oligodendrocyte progenitor cell maturation by PPARδ: effects on bone morphogenetic proteins.

Authors:  Maria Vittoria Simonini; Paul E Polak; Anne I Boullerne; Jeffrey M Peters; Jill C Richardson; Douglas L Feinstein
Journal:  ASN Neuro       Date:  2010-01-15       Impact factor: 5.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.